Skip to main content
AXSM logo

AXSM · Axsome Therapeutics, Inc.

$241.53 +1.91 (+0.80%) At close · Jul 23
Market Cap
$12.43B
Shares
51.46M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Herriot Tabuteau $10,283,492
Mark Jacobson $4,208,131
Nick Pizzie $3,730,519
Hunter Murdock $3,224,304
Ari Maizel $3,188,657
Fiscal 2024
Executive Total
Herriot Tabuteau $10,364,688
Mark Jacobson $4,245,813
Nick Pizzie $3,756,389
General Counsel $3,245,542
Hunter Murdock $3,245,542
Ari Maizel $3,198,507
Fiscal 2023
Executive Total
Herriot Tabuteau $9,896,629
Mark Jacobson $4,036,250
Ari Maizel $3,920,771
Nick Pizzie $3,565,817
General Counsel $3,057,530
Hunter Murdock $3,057,530
Fiscal 2022
Executive Total
Herriot Tabuteau $8,322,402
Mark Jacobson $3,785,242
Nick Pizzie $3,333,457
Hunter Murdock $2,484,699
General Counsel $2,484,699
Fiscal 2021
Executive Total
Herriot Tabuteau $8,054,631
Mark Jacobson $4,794,824
Nick Pizzie $4,228,710
General Counsel $374,431
Fiscal 2020
Executive Total
Herriot Tabuteau $7,304,689
Mark Jacobson $2,365,005
Nick Pizzie $2,365,005
Fiscal 2019
Executive Total
Herriot Tabuteau $4,715,753
David Marek $2,969,931
Mark Jacobson $1,955,681
Nick Pizzie $1,569,837
Fiscal 2018
Executive Total
Herriot Tabuteau $1,057,425
Nick Pizzie $687,981
Fiscal 2017
Executive Total
Herriot Tabuteau $1,123,352
Key facts CIK 1579428 CUSIP 05464T104 13F (30d) 64 filings 63 filers Visit website Investor relations